NASH with any fibrosis stage was trending towards significance in PCE (OR [95% CI] for PCE: 1.66 [0.96, 2.86] and for FRS: 1.23 [0.58, 2.58]) ( Table 2 ).
← all excerpts
Cardiovascular risk in US adults with nonalcoholic steatohepatitis (NASH) vs. matched non-NASH controls, National Health and Nutrition Examination Survey, 2017-2020.
1
—
—